Real Deal With Ron Sivak

November is purple-ribboned pancreatic cancer month and, unfortunately, it is a death sentence. The third most fatal (and least funded) among a 100+ family of feared diseases, it recently passed October's pink-ribboned cousin, breast cancer, in mortality rates. 95 percent of those diagnosed today won't live past five years. 75 percent won't survive one. Average life expectancy? Three to six months. There is no early warning test. There are no reliable symptoms. Family history is a marginal indicator. It's the only form of cancer where no significant mitigating advancements have been made in 40 years and is expected to pass colorectal cancer as the second leading killer in the U.S. by 2030. What if I told you that the script could be flipped? A death sentence commuted. A second lease on life made possible. A modern miracle. Would you be thankful? Click to hear the full Dr. Finan Interview In this holiday edition of Lagniappe's Real Deal Podcast, Ron Sivak and Johnny G. interviewed Dr. Michael Finan, Direc